AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,049 | -27.1% | 15 | -25.0% | 0.00% | -100.0% |
| Q2 2023 | $1,438 | +16.5% | 20 | 0.0% | 0.00% | – |
| Q1 2023 | $1,234 | -98.4% | 20 | -98.0% | 0.00% | -100.0% |
| Q4 2022 | $78,673 | +87.3% | 1,020 | -7.3% | 0.03% | +60.0% |
| Q3 2022 | $42,000 | 0.0% | 1,100 | 0.0% | 0.02% | +17.6% |
| Q2 2022 | $42,000 | -16.0% | 1,100 | -8.3% | 0.02% | -5.6% |
| Q1 2022 | $50,000 | +47.1% | 1,200 | +33.3% | 0.02% | +38.5% |
| Q4 2021 | $34,000 | +13.3% | 900 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $30,000 | – | 900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |